IFLENZEA Trademark

Trademark Overview

On Tuesday, July 21, 2015, a trademark application was filed for IFLENZEA with the United States Patent and Trademark Office. The USPTO has given the IFLENZEA trademark a serial number of 79172675. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, August 12, 2022. This trademark is owned by NOVARTIS AG. The IFLENZEA trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
iflenzea

General Information

Serial Number79172675
Word MarkIFLENZEA
Filing DateTuesday, July 21, 2015
Status709 - CANCELLED - SECTION 71
Status DateFriday, August 12, 2022
Registration Number4891075
Registration DateTuesday, January 26, 2016
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 10, 2015

Trademark Statements

Goods and ServicesVaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, August 12, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSeqirus UK Limited
Party Type30 - Original Registrant
Legal Entity Type98 - Unknown
AddressGB
Party NameSeqirus UK Limited
Party Type21 - New Owner After Publication
Legal Entity Type98 - Unknown
AddressGB
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Thursday, September 17, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, September 18, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 22, 2015APPLICATION FILING RECEIPT MAILED
Thursday, September 24, 2015ASSIGNED TO EXAMINER
Monday, September 28, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 21, 2015NOTICE OF PUBLICATION
Wednesday, November 4, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 4, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, November 10, 2015PUBLISHED FOR OPPOSITION
Sunday, November 15, 2015CHANGE OF OWNER RECEIVED FROM IB
Friday, November 20, 2015NOTIFICATION PROCESSED BY IB
Tuesday, January 26, 2016REGISTERED-PRINCIPAL REGISTER
Thursday, February 25, 2016GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, April 19, 2016FINAL DISPOSITION PROCESSED
Tuesday, April 19, 2016FINAL DISPOSITION NOTICE SENT TO IB
Friday, August 19, 2016NOTIFICATION PROCESSED BY IB
Thursday, September 29, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 29, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 3, 2016CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, January 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 23, 2017REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Thursday, June 6, 2019NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, January 26, 2021COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, August 12, 2022CANCELLED SECTION 71
Wednesday, April 12, 2023TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Wednesday, May 24, 2023INVALIDATION PROCESSED
Wednesday, May 24, 2023TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sunday, June 18, 2023TOTAL INVALIDATION PROCESSED BY THE IB
Friday, January 5, 2024NEW REPRESENTATIVE AT IB RECEIVED
Friday, January 3, 2025NEW REPRESENTATIVE AT IB RECEIVED

Related Keywords

iflenzea human vaccines